Yingke Medical: Revenue of 9.926 billion yuan in 2025, with a year-on-year decrease in net profit of 31.03%.

The announcement of Yingke Medical stated that the revenue in 2025 was 9.926 billion yuan, a year-on-year increase of 4.23%; the net profit attributable to the shareholders of the listed company was 1.011 billion yuan, a year-on-year decrease of 31.03%. The company plans to distribute cash dividends of 1 yuan for every 10 shares to all shareholders based on the total share capital after deducting the repurchased shares in the account on the record date for the implementation of the equity distribution. In addition, in 2025, the company completed the cancellation of 4.5043 million repurchased shares in 2023; the controlling shareholder, Liu Fangyi, released a pledge of 1 million shares, with a total of 6.65 million shares pledged; a total of 3.3062 million shares were repurchased, with a total transaction amount of 80.007 million yuan; and the subscribed capital of Haining Qingchuan Entrepreneurship Investment Partnership Enterprise was changed to 28.7727 million yuan.